cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.31287655.v1
title: Supplementary material from A bio-inspired configuration and algorithm for vibration source localization and its biological implications

description: The supplementary material for the manuscript
DOI: 10.15468/e4p3nm
title: 2025_Monitoring_of_Invasive_Alien_Species_in_the_Korean_PI_1

description: These records are provided by the National Science Museum of Korea through the National Natural History Research Information System.
The dataset contains curated biodiversity occurrence records generated through a citizen-participatory monitoring project, in which citizen participants contribute biodiversity observations from their local regions.
Citizen-contributed observation records were subsequently taxonomically identified and validated under institutional data curation workflows.
DOI: 10.3886/e245133
title: حبوب الإجهاض في البحرين)][(₊✩‧₊˚౨)][( +971521786258 )][(ৎ˚₊✩‧₊)]( أقراص ميفيبريستون وميزوبروستول للبيع في البحرين، حبوب سايتوتك متوفرة في البحرين

description: حبوب الإجهاض في البحرين)][(₊✩‧₊˚౨)][( +971521786258 )][(ৎ˚₊✩‧₊)]( أقراص ميفيبريستون وميزوبروستول للبيع في البحرين، حبوب سايتوتك متوفرة في البحرين حبوب الإجهاض في البحرين)][(₊✩‧₊˚౨)][( +971521786258 )][(ৎ˚₊✩‧₊)]( أقراص ميفيبريستون وميزوبروستول للبيع في البحرين، حبوب سايتوتك متوفرة في البحرين حبوب الإجهاض في البحرين)][(₊✩‧₊˚౨)][( +971521786258 )][(ৎ˚₊✩‧₊)]( أقراص ميفيبريستون وميزوبروستول للبيع في البحرين، حبوب سايتوتك متوفرة في البحرين حبوب الإجهاض في البحرين)][(₊✩‧₊˚౨)][( +971521786258 )][(ৎ˚₊✩‧₊)]( أقراص ميفيبريستون وميزوبروستول للبيع في البحرين، حبوب سايتوتك متوفرة في البحرين حبوب الإجهاض في البحرين)][(₊✩‧₊˚౨)][( +971521786258 )][(ৎ˚₊✩‧₊)]( أقراص ميفيبريستون وميزوبروستول للبيع في البحرين، حبوب سايتوتك متوفرة في البحرين
DOI: 10.5281/zenodo.17296750
title: Bavarian Danube Water Level Reconstruction (1826-1894)

description: This data set provides digitised daily water-level series reconstructed from nineteenth-century archival charts for three Bavarian Danube gauges (Neu-Ulm, Vilshofen, Passau), overall 75,395 data points, covering the years 1826 to 1894 completely. The original sources are hand-drawn annual water-level charts preserved in the Bavarian State Archives. We convert these analogue records into machine-readable series using a documented computer-vision workflow, complemented by manual quality control and method tracking.

For further details, read the data_descriptor.pdf included.
DOI: 10.5281/zenodo.17296751
title: Bavarian Danube Water Level Reconstruction (1826-1894)

description: This data set provides digitised daily water-level series reconstructed from nineteenth-century archival charts for three Bavarian Danube gauges (Neu-Ulm, Vilshofen, Passau), overall 75,395 data points, covering the years 1826 to 1894 completely. The original sources are hand-drawn annual water-level charts preserved in the Bavarian State Archives. We convert these analogue records into machine-readable series using a documented computer-vision workflow, complemented by manual quality control and method tracking.

For further details, read the data_descriptor.pdf included.
DOI: 10.5281/zenodo.18617656
title: UNLOCKING EMPLOYEE INNOVATIVE BEHAVIOUR: EXPLORING THE POWER OF TRANSFORMATIONAL LEADERSHIP AND TACIT KNOWLEDGE SHARING AMONG INDONESIAN WHITE-COLLAR WORKERS
DOI: 10.5281/zenodo.18617655
title: UNLOCKING EMPLOYEE INNOVATIVE BEHAVIOUR: EXPLORING THE POWER OF TRANSFORMATIONAL LEADERSHIP AND TACIT KNOWLEDGE SHARING AMONG INDONESIAN WHITE-COLLAR WORKERS
DOI: 10.15468/dl.xrehwp
title: Occurrence Download

description: A dataset containing 1202 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is one of (Machine Observation, Human Observation)",
 "Country is one of (Chinese Taipei, China)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Viverricula indica",
 "Year 2000-2026"
 ]
}

 The dataset includes 1202 records from 8 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010818-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.bch5mz
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Capparis neriifolia",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is Fossil"
 ]
 }
 }
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010814-260208012135463/datasets/export for details.
DOI: 10.15468/dl.qqyhex
title: Occurrence Download

description: A dataset containing 60 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Thismia rodwayi",
 "HasCoordinate is true",
 "BasisOfRecord is one of (Specimen)"
 ]
}

 The dataset includes 60 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010817-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.57ru78
title: Occurrence Download

description: A dataset containing 7 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "Year is greater than or equal to 1900",
 "TaxonKey is Cyperus albomarginatus"
 ]
}

 The dataset includes 7 records from 6 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010815-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.7p8qaq
title: Occurrence Download

description: A dataset containing 13562 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON ((16.455950133610717 48.22959982489137, 16.59522881296117 48.221349638055365, 16.60751297471701 48.315100989696305, 16.4679783261995 48.323368852623425, 16.455950133610717 48.22959982489137))"
 ]
}

 The dataset includes 13562 records from 75 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010816-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.3886/e245134
title: Abortion Pills In Al Ain| )][(་༘࿐✓|+971521553488 )][(───୨900ৎ───( APPROVED FULL KIT ), | Mifepristone And Misoprostol Medicine Available In Al Ain

description: Abortion Pills In Al Ain| )][(་༘࿐✓|+971521553488 )][(───୨900ৎ───( APPROVED FULL KIT ), | Mifepristone And Misoprostol Medicine Available In Al AinAbortion Pills In Al Ain| )][(་༘࿐✓|+971521553488 )][(───୨900ৎ───( APPROVED FULL KIT ), | Mifepristone And Misoprostol Medicine Available In Al AinAbortion Pills In Al Ain| )][(་༘࿐✓|+971521553488 )][(───୨900ৎ───( APPROVED FULL KIT ), | Mifepristone And Misoprostol Medicine Available In Al AinAbortion Pills In Al Ain| )][(་༘࿐✓|+971521553488 )][(───୨900ৎ───( APPROVED FULL KIT ), | Mifepristone And Misoprostol Medicine Available In Al AinAbortion Pills In Al Ain| )][(་༘࿐✓|+971521553488 )][(───୨900ৎ───( APPROVED FULL KIT ), | Mifepristone And Misoprostol Medicine Available In Al AinAbortion Pills In Al Ain| )][(་༘࿐✓|+971521553488 )][(───୨900ৎ───( APPROVED FULL KIT ), | Mifepristone And Misoprostol Medicine Available In Al Ain
DOI: 10.15468/dl.j559xc
title: Occurrence Download

description: A dataset containing 107365 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Kurtiella",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 107365 records from 352 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010787-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.31323088
title: Supplementary Material for: Continuous versus Intermittent Hydrocortisone for the Treatment of Septic Shock: A Systematic Review and Meta-Analysis

description: Objectives: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) and comparative cohort studies comparing continuous with intermittent intravenous hydrocortisone in adults with septic shock. Subjects and Methods: Searches of MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were conducted till July 2025. The primary outcome was all-cause mortality; secondary outcomes included hospital and ICU length of stay, shock reversal, hypernatremia, hypokalemia, and vasopressor use. Risk of bias was assessed using Cochrane RoB 2.0 for RCTs and the Newcastle–Ottawa Scale for cohort studies. A random-effects model was applied, and certainty of evidence was graded with GRADE. Results: Eight studies (five RCTs, three cohort studies) including 609 patients were analyzed. Continuous infusion was not associated with a significant reduction in mortality compared with intermittent infusion (RR 0.83, 95% CI 0.65–1.06; p=0.13; I²=36%). No significant differences were observed in hospital stay (MD 0.10 days, 95% CI –1.40 to 1.61), ICU stay (MD –0.02 days, 95% CI –0.63 to 0.58), shock reversal (RR 0.94, 95% CI 0.61–1.46), hypernatremia (RR 1.05, 95% CI 0.51–2.16), hypokalemia (RR 0.64, 95% CI 0.40–1.03), or vasopressor duration (MD –0.97 days, 95% CI –4.00 to 2.05). Certainty of evidence ranged from very low to moderate. Conclusion: Continuous and intermittent hydrocortisone infusion demonstrated comparable clinical outcomes in septic shock. Large, multicenter RCTs are warranted to determine the optimal administration strategy.
DOI: 10.6084/m9.figshare.31323088.v1
title: Supplementary Material for: Continuous versus Intermittent Hydrocortisone for the Treatment of Septic Shock: A Systematic Review and Meta-Analysis

description: Objectives: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) and comparative cohort studies comparing continuous with intermittent intravenous hydrocortisone in adults with septic shock. Subjects and Methods: Searches of MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were conducted till July 2025. The primary outcome was all-cause mortality; secondary outcomes included hospital and ICU length of stay, shock reversal, hypernatremia, hypokalemia, and vasopressor use. Risk of bias was assessed using Cochrane RoB 2.0 for RCTs and the Newcastle–Ottawa Scale for cohort studies. A random-effects model was applied, and certainty of evidence was graded with GRADE. Results: Eight studies (five RCTs, three cohort studies) including 609 patients were analyzed. Continuous infusion was not associated with a significant reduction in mortality compared with intermittent infusion (RR 0.83, 95% CI 0.65–1.06; p=0.13; I²=36%). No significant differences were observed in hospital stay (MD 0.10 days, 95% CI –1.40 to 1.61), ICU stay (MD –0.02 days, 95% CI –0.63 to 0.58), shock reversal (RR 0.94, 95% CI 0.61–1.46), hypernatremia (RR 1.05, 95% CI 0.51–2.16), hypokalemia (RR 0.64, 95% CI 0.40–1.03), or vasopressor duration (MD –0.97 days, 95% CI –4.00 to 2.05). Certainty of evidence ranged from very low to moderate. Conclusion: Continuous and intermittent hydrocortisone infusion demonstrated comparable clinical outcomes in septic shock. Large, multicenter RCTs are warranted to determine the optimal administration strategy.
DOI: 10.6084/m9.figshare.31323094
title: Supplementary Material for: Photodynamic Therapy for Central Early-Stage Lung Cancer: A Retrospective Comparative Study of Photofrin, Chlorin e6, and Foscan

description: Introduction:
Photodynamic therapy (PDT) is a minimally invasive, organ-preserving treatment option for patients with centrally located early-stage non-small cell lung cancer (NSCLC). While first-generation photosensitizers such as Photofrin are well established, second-generation agents like Chlorin e6 offer improved pharmacokinetics and potentially better clinical outcomes. The objective of this study was to assess the safety profile and therapeutic efficacy of different photosensitizers used in PDT for centrally located early-stage lung cancer (CELC).

Methods:
We retrospectively analyzed 62 CELC lesions in 36 patients treated with PDT between 2015 and 2024. Patients received one of three photosensitizers—Photofrin, Chlorin e6, or Foscan—followed by bronchoscopic light activation. Outcomes included complete remission (CR), local tumor control (LTC), disease-free survival (DFS), and treatment-related adverse events.

Results:
CR rates were 87.5% (28/32) for Chlorin e6, 100% (3/3) for Foscan, and 68.8% (22/32) for Photofrin, with a non-significant trend favoring Chlorin e6 over Photofrin (p = 0.13). Mean DFS was longest in the Chlorin e6 group (43.3 months; 95% CI: 32.5–54.1), followed by Photofrin (24.0 months; 95% CI: 17.2–30.8) and Foscan (7.3 months; 95% CI: 6.3–8.4). Durable LTC was achieved in 84.1% of lesions without need for escalation to systemic or surgical treatment. Chlorin e6 demonstrated a more favorable safety profile than Photofrin.

Conclusion:
PDT is a safe and effective treatment modality for centrally located early-stage lung cancer, achieving high rates of local tumor control. Among the evaluated photosensitizers, Chlorin e6 showed a favorable balance of efficacy and safety.
DOI: 10.6084/m9.figshare.31323094.v1
title: Supplementary Material for: Photodynamic Therapy for Central Early-Stage Lung Cancer: A Retrospective Comparative Study of Photofrin, Chlorin e6, and Foscan

description: Introduction:
Photodynamic therapy (PDT) is a minimally invasive, organ-preserving treatment option for patients with centrally located early-stage non-small cell lung cancer (NSCLC). While first-generation photosensitizers such as Photofrin are well established, second-generation agents like Chlorin e6 offer improved pharmacokinetics and potentially better clinical outcomes. The objective of this study was to assess the safety profile and therapeutic efficacy of different photosensitizers used in PDT for centrally located early-stage lung cancer (CELC).

Methods:
We retrospectively analyzed 62 CELC lesions in 36 patients treated with PDT between 2015 and 2024. Patients received one of three photosensitizers—Photofrin, Chlorin e6, or Foscan—followed by bronchoscopic light activation. Outcomes included complete remission (CR), local tumor control (LTC), disease-free survival (DFS), and treatment-related adverse events.

Results:
CR rates were 87.5% (28/32) for Chlorin e6, 100% (3/3) for Foscan, and 68.8% (22/32) for Photofrin, with a non-significant trend favoring Chlorin e6 over Photofrin (p = 0.13). Mean DFS was longest in the Chlorin e6 group (43.3 months; 95% CI: 32.5–54.1), followed by Photofrin (24.0 months; 95% CI: 17.2–30.8) and Foscan (7.3 months; 95% CI: 6.3–8.4). Durable LTC was achieved in 84.1% of lesions without need for escalation to systemic or surgical treatment. Chlorin e6 demonstrated a more favorable safety profile than Photofrin.

Conclusion:
PDT is a safe and effective treatment modality for centrally located early-stage lung cancer, achieving high rates of local tumor control. Among the evaluated photosensitizers, Chlorin e6 showed a favorable balance of efficacy and safety.
DOI: 10.6084/m9.figshare.31323097
title: Supplementary Material for: Brief Cognitive-Behavioral Insomnia Treatment for Primary Care Veterans at Elevated Risk for Suicide: A Randomized Clinical Trial

description: Introduction: Many patients at risk for suicide present in primary care where insomnia and other suicide risk factors are prevalent. Addressing insomnia in this milieu may augment suicide prevention strategies.
Methods: A randomized clinical trial was conducted to test the effectiveness of brief cognitive behavioral therapy for insomnia (bCBTi) for primary care patients at risk for suicide recruited from three U.S. Veterans Health Administration practices. The 194 participants (77% male; mean age 51.5+/-13.6 years) with insomnia, co-occurring depression and/or posttraumatic stress disorder (PTSD) and recent death or suicide ideation were randomized to receive four 30-minute sessions of bCBTi or Sleep Hygiene over six weeks. Blinded assessments occurred every 6 weeks from baseline to 30 weeks. Change in Insomnia Severity Index (ISI) across 30 weeks was the primary outcome with co-secondary outcomes measured by the Scale for Suicidal Ideation (SSI), Patient Health Questionnaire-9 (PHQ-9) and PTSD Checklist (PCL).
Results: Mixed level modeling showed a significant condition effect at posttreatment (6-weeks) for ISI favoring bCBTi (t(df) = -4.58(153); p &lt; .0001) which was maintained through 30-weeks (t(df) = 0.35(141); p &gt;.05). PHQ-9 was lower at 6 weeks in the bCBTi condition (t(df) = -2.07(155); p = .04) maintained through 30 weeks (t(df) = -0.47(137); p &gt; .05). No PCL differences and no difference in SSI at posttreatment. However, a significant timexcondition effect from 6 to 30 weeks existed for SSI favoring bCBTi (t(df) = -2.60(118); p = 0.01).
Conclusion: The bCBTi intervention designed for primary care settings effectively reduces insomnia severity with modest effects for depression and suicidal thoughts, offering an adjuvant to suicide prevention strategies.
DOI: 10.6084/m9.figshare.31323097.v1
title: Supplementary Material for: Brief Cognitive-Behavioral Insomnia Treatment for Primary Care Veterans at Elevated Risk for Suicide: A Randomized Clinical Trial

description: Introduction: Many patients at risk for suicide present in primary care where insomnia and other suicide risk factors are prevalent. Addressing insomnia in this milieu may augment suicide prevention strategies.
Methods: A randomized clinical trial was conducted to test the effectiveness of brief cognitive behavioral therapy for insomnia (bCBTi) for primary care patients at risk for suicide recruited from three U.S. Veterans Health Administration practices. The 194 participants (77% male; mean age 51.5+/-13.6 years) with insomnia, co-occurring depression and/or posttraumatic stress disorder (PTSD) and recent death or suicide ideation were randomized to receive four 30-minute sessions of bCBTi or Sleep Hygiene over six weeks. Blinded assessments occurred every 6 weeks from baseline to 30 weeks. Change in Insomnia Severity Index (ISI) across 30 weeks was the primary outcome with co-secondary outcomes measured by the Scale for Suicidal Ideation (SSI), Patient Health Questionnaire-9 (PHQ-9) and PTSD Checklist (PCL).
Results: Mixed level modeling showed a significant condition effect at posttreatment (6-weeks) for ISI favoring bCBTi (t(df) = -4.58(153); p &lt; .0001) which was maintained through 30-weeks (t(df) = 0.35(141); p &gt;.05). PHQ-9 was lower at 6 weeks in the bCBTi condition (t(df) = -2.07(155); p = .04) maintained through 30 weeks (t(df) = -0.47(137); p &gt; .05). No PCL differences and no difference in SSI at posttreatment. However, a significant timexcondition effect from 6 to 30 weeks existed for SSI favoring bCBTi (t(df) = -2.60(118); p = 0.01).
Conclusion: The bCBTi intervention designed for primary care settings effectively reduces insomnia severity with modest effects for depression and suicidal thoughts, offering an adjuvant to suicide prevention strategies.
DOI: 10.6084/m9.figshare.31323100
title: Supplementary Material for: A novel decision-making protocol for the prediction of sperm retrieval in Klinefelter's Syndrome patients

description: Introduction
To develop a preliminary, decision-making protocol capable of predicting sperm retrieval success in non-mosaic Klinefelter's syndrome (KS) patients. Main outcome was to identify predictors of successful sperm retrieval and to build a decision-making protocol capable of predicting this success by assessing several variables including age, testicular volume and pre-operative hormonal responses.
Methods
A retrospective cohort study included all men with non-mosaic KS who were treated with recombinant hCG and then underwent microdissection testicular sperm extraction (micro-TESE) between December 2019 and March 2023.
Results
Thirty-eight patients who were treated medically with rec-hCG prior to their micro-TESE were included. Sperm was retrieved successfully from 28 patients (73.7%). Initial testosterone differences between the groups were small and not significant, the mean pre-op (post hormonal treatment) testosterone between the two groups was significant (P =0.001). We then built a decision making tree, in which Testosterone change was the primary determining factor for successful sperm retrieval, testicular volume was a contributory secondary variable, and age was a tertiary consideration in cases of low
testicular volume. Using this model, we observed the highest success rates (97%) in men with testosterone change of 9 nmol/l or more and testicular volume of 3 cc or more. on the other hand, men with no testosterone change with hormonal treatment, low testicular volume who were 25 years old or more had a success rate of only 63%.
Conclusion
This study proposes a preliminary, decision-making protocol capable of predicting sperm retrieval success in non-mosaic KS patients. This model can be used as part of an individualized counselling approach. External validation is essential to corroborate our preliminary results.
DOI: 10.6084/m9.figshare.31323100.v1
title: Supplementary Material for: A novel decision-making protocol for the prediction of sperm retrieval in Klinefelter's Syndrome patients

description: Introduction
To develop a preliminary, decision-making protocol capable of predicting sperm retrieval success in non-mosaic Klinefelter's syndrome (KS) patients. Main outcome was to identify predictors of successful sperm retrieval and to build a decision-making protocol capable of predicting this success by assessing several variables including age, testicular volume and pre-operative hormonal responses.
Methods
A retrospective cohort study included all men with non-mosaic KS who were treated with recombinant hCG and then underwent microdissection testicular sperm extraction (micro-TESE) between December 2019 and March 2023.
Results
Thirty-eight patients who were treated medically with rec-hCG prior to their micro-TESE were included. Sperm was retrieved successfully from 28 patients (73.7%). Initial testosterone differences between the groups were small and not significant, the mean pre-op (post hormonal treatment) testosterone between the two groups was significant (P =0.001). We then built a decision making tree, in which Testosterone change was the primary determining factor for successful sperm retrieval, testicular volume was a contributory secondary variable, and age was a tertiary consideration in cases of low
testicular volume. Using this model, we observed the highest success rates (97%) in men with testosterone change of 9 nmol/l or more and testicular volume of 3 cc or more. on the other hand, men with no testosterone change with hormonal treatment, low testicular volume who were 25 years old or more had a success rate of only 63%.
Conclusion
This study proposes a preliminary, decision-making protocol capable of predicting sperm retrieval success in non-mosaic KS patients. This model can be used as part of an individualized counselling approach. External validation is essential to corroborate our preliminary results.
DOI: 10.15468/dl.r4kt82
title: Occurrence Download

description: A dataset containing 3584 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is India",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Parthenium hysterophorus",
 "Year 2000-2026"
 ]
}

 The dataset includes 3584 records from 16 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010819-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.